{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:20:32Z","timestamp":1791429632372,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jdiacomp.2022.108356","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T12:22:35Z","timestamp":1667910155000},"page":"108356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus"],"prefix":"10.1016","volume":"36","author":[{"given":"Stella","family":"Papachristou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Pafili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Trypsianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Papazoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u039aonstantinos","family":"Vadikolias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2022.108356_bb0005","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.2337\/dc22-S012","article-title":"12. Retinopathy, neuropathy, and foot care: standards of medical care in diabetes-2022","volume":"45","author":"Committee","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/er.2018-00107","article-title":"Emerging biomarkers, tools, and treatments for diabetic polyneuropathy","volume":"40","author":"B\u00f6nhof","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s13300-020-00776-3","article-title":"Diabetic neuropathy collection: progress in diagnosis and screening","volume":"11","author":"Papanas","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molmet.2013.11.006","article-title":"Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms","volume":"3","author":"Stirban","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12902-021-00697-7","article-title":"Skin AGEs and diabetic neuropathy","volume":"21","author":"Papachristou","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0030","article-title":"Advanced glycation end products: do they impair bone health in diabetes?","author":"Papachristou","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0035","doi-asserted-by":"crossref","first-page":"6045677","DOI":"10.1155\/2021\/6045677","article-title":"Skin advanced glycation end products among subjects with type 2 diabetes mellitus with or without distal sensorimotor polyneuropathy","volume":"2021","author":"Papachristou","year":"2021","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0040","article-title":"Correlation between skin advanced glycation end products and cardiac autonomic neuropathy among subjects with type 2 diabetes mellitus","author":"Papachristou","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5114\/aoms.2016.59265","article-title":"Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus","volume":"12","author":"Chatzikosma","year":"2016","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0050","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/dme.12000","article-title":"A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy","volume":"30","author":"Papanas","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0055","unstructured":"AGE reader mu connect (Diagnoptics, NL). Instructions for use, version 2.1. Available at: www.diagnoptics.com\/wp-content\/uploads\/2020\/11\/Installation-guide-for-AGE-Reader-mu-app-V2.0.1-1.pdf."},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0065","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jdiacomp.2018.06.014","article-title":"Skin autofluorescence: correlation with measures of diabetic sensorimotor neuropathy","volume":"32","author":"Stirban","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1464-5491.2011.03448.x","article-title":"Skin autofluorescence is associated with severity of vascular complications in Japanese patients with type 2 diabetes","volume":"29","author":"Tanaka","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0075","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jdiacomp.2018.06.009","article-title":"Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes","volume":"32","author":"Osawa","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2020.100038","article-title":"Skin autofluorescence, a marker of glucose memory in type 2 diabetes","volume":"7","author":"Rigo","year":"2020","journal-title":"Metabol Open"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/gtmb.2018.0328","article-title":"Skin autofluorescence is associated with diabetic peripheral neuropathy in chinese patients with type 2 diabetes: a cross-sectional study","volume":"23","author":"Wan","year":"2019","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12902-021-00725-6","article-title":"Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0095","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00125-005-1828-x","article-title":"Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy","volume":"48","author":"Meerwaldt","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0100","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/dc10-1791","article-title":"Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes","volume":"34","author":"Conway","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/a-0972-1302","article-title":"Endothelial and autonomic dysfunction at early stages of glucose intolerance and in metabolic syndrome","volume":"52","author":"Dimova","year":"2020","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ptj\/85.3.257","article-title":"The kappa statistic in reliability studies: use, interpretation, and sample size requirements","volume":"85","author":"Sim","year":"2005","journal-title":"Phys Ther"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108356_bb0120","doi-asserted-by":"crossref","first-page":"6662159","DOI":"10.1155\/2021\/6662159","article-title":"Association of cardiovascular autonomic neuropathy and distal symmetric polyneuropathy with all-cause mortality: a retrospective cohort study","volume":"2021","author":"V\u00e1gi","year":"2021","journal-title":"J Diabetes Res"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722002689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722002689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:16:13Z","timestamp":1761005773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872722002689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1056872722002689"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108356","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022","name":"copyright","label":"Copyright"}],"article-number":"108356"}}